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Abstract: Seafood is assumed to be beneficial for cardiovascular health, mainly based on 
plasma lipid lowering and anti-inflammatory effects of n-3 polyunsaturated fatty acids. 
However, other plasma risk factors linked to cardiovascular disease are less studied.  
This study aimed to penetrate the effect of a phospholipid-protein complex (PPC) from 
Antarctic krill on one-carbon metabolism and production of trimethylamine-N-oxide 
(TMAO) in rats. Male Wistar rats were fed isoenergetic control, 6%, or 11% PPC diets for 
four weeks. Rats fed PPC had reduced total homocysteine plasma level and increased 
levels of choline, dimethylglycine and cysteine, whereas the plasma level of methionine 
was unchanged compared to control. PPC feeding increased the plasma level of TMAO, 
carnitine, its precursors trimethyllysine and γ-butyrobetaine. There was a close correlation 
between plasma TMAO and carnitine, trimethyllysine, and γ-butyrobetaine, but not 
between TMAO and choline. The present data suggest that PPC has a homocysteine 
lowering effect and is associated with altered plasma concentrations of metabolites related 
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to one-carbon metabolism and B-vitamin status in rats. Moreover, the present study reveals 
a non-obligatory role of gut microbiota in the increased plasma TMAO level as it can be 
explained by the PPC’s content of TMAO. The increased level of carnitine and carnitine 
precursors is interpreted to reflect increased carnitine biosynthesis. 
Keywords: phospholipid-protein complex; Omega-3 polyunsaturated fatty acids; Euphausia 
superba; one-carbon metabolism; homocysteine; trimethylamine-N-oxide; carnitine 
 
1. Introduction 
Fish oil, enriched by long-chain n-3 PUFAs as eicosapentaenoic acid (EPA) and docosahexaenoic 
acid (DHA), is reported to have protective roles against arteriosclerotic- and cardiovascular diseases [1,2]. 
It has lately been suggested that some of the beneficial influence of seafood on health could arise from 
the protein fraction, and studies in rodents have shown that a number of fish hydrolysates have lipid 
lowering and antioxidant effects [3,4]. Antarctic krill (Euphausia superba) has a high protein and lipid 
content, and has mainly been utilized as a novel source of n-3 PUFAs. While krill supplements have 
been shown to reduce plasma lipid levels in rodent and human studies [5,6], the effect on other risk 
factors involved in cardiovascular disease has not been analyzed. 
Elevated plasma total homocysteine (tHcy) increases the likelihood of endothelial cell injury and 
has been implicated as an independent risk factor for atherosclerotic and cardiovascular disease [7], 
although its direct association to ischemic stroke has been disputed in recent meta-analyses [8,9]. 
Plasma tHcy have further been demonstrated to be inversely associated to plasma levels of folate 
(vitamin B9), cobalamin (vitamin-B12) and pyroxidal phosphate (vitamin B6), the three vitamins 
involved in the conversion of homocysteine (Hcy) to methionine (Met) or cysteine [10,11]. However, 
vitamin B interventions have not been able to prevent cardiovascular events [12]. Hcy, a sulfur-containing, 
non-protein amino acid, is not obtained from the diet—it is generated from S-adenosylhomocysteine 
(SAH) via the S-adenosyhomocysteine hydrolase during methylation processes in the body [13]. 
Remethylation of Hcy back to Met is catalyzed by Met synthase (MS) with 5-methyltetrahydrofolate  
(5-mTHF) as the methyl donor [14,15]. Cobalamin (vitamin B12) is a cofactor in this enzymatic 
reaction (Figure 1). This step takes place in all tissues, but in liver and kidney Hcy can also be 
remethylated to Met by the zinc metalloenzyme betaine-Hcy S-methyltransferase (BHMT) [16–18]. 
Betaine is the methyl donor for BHMT and the products are Met and dimethylglycine (DMG). Met can 
further be catabolized to Met sulfoxide by the niacin (vitamin B3)-dependent Met sulfoxide reductase A 
(MSR) [19]. Finally, Hcy catabolism through the transsulfuration pathway to form cysteine is carried 
out by two pyridoxine (vitamin B6)-dependent enzymes, cystathionine-beta synthase (CBS) and 
cystathionine gamma-lyase (CTH). Hcy has been suggested to promote atherosclerosis by elevating 
levels of reactive oxygen species [20], as well as through effects on lipoprotein metabolism [21]. 
Dietary interventions influencing both Hcy and plasma lipid levels could potentially be beneficial for 
health. Both n-3 polyunsaturated fatty acids (PUFAs) [22], and diets with different amino acid 
composition [23], have been reported to reduce serum tHcy levels. 




Figure 1. Metabolites of the folate cycle, transsulfuration pathway, and methionine  
(Met)-homocysteine (Hcy) cycle. Enzymes are shown in grey boxes, and their vitamin  
co-factors in green circles. Abbreviations: PC, phosphatidylcholine; MetSO, methionine 
sulfoxide, TMA, trimethylamine; TMAO, trimethylamine-N-oxide; FMO, flavin-containing 
monooxygenase; BHMT, betaine homocysteine methyltransferase; DMG, dimethylglycine; 
CTH, cystathionine gamma lyase; CBS, cystathionine beta-synthase; MS, methionine 
synthase/5-methyltetrahydrofolate-homocysteine methyltransferase (MTR); THF, 
tetrahydrofolate; 5-mTHF, 5-methyltetrahydrofolate; 5,10-mTHF, 5,10-
methylenetetrahydrofolate; MTHFR, methylenetetrahydrofolate reductase (NAD(P)H); 
MSR, methionine synthase reductase. 
The majority of the n-3 PUFAs in krill oil is associated with phospholipids, in particular 
phosphatidylcholine (PC), while in fish oil the PUFAs are in the form of triacylglycerol (TAG) or fatty 
acid ethyl esters. The phospholipid PC is the major dietary source of choline and it was recently 
reported that microbiota metabolizes choline to form trimethylamine (TMA), which can be oxidized by 
the vitamin-B2 dependent enzyme flavin adenine monomaine oxidase (FMO) in the liver to produce 
trimethylamine-N-oxide (TMAO) (Figure 1) [24,25]. Metabolism of dietary carnitine by intestinal 
microbiota has also been found to produce TMAO [26]. Intestinal microbial metabolism of PC and 
carnitine has been found to promote arteriosclerosis and is associated with an increased risk of incident 
major adverse cardiovascular events, but only among subjects with high TMAO levels [25,27]. 
Nevertheless, it is important to note that TMAO has beneficial effects in marine animals; TMAO is a 
common and compatible osmolyte in muscle tissues that protects proteins against various destabilizing 
forces [28]. It is reported that TMAO counteract the toxic effects of urea and ammonia on proteins [29], 
and may also depress the freezing point and counteract the effect of hydrostatic pressure of enzyme 
function in deep-sea animals [28,30,31]. 
The aim of the present study was to provide insight into effects of a phospholipid-protein complex 
(PPC) from krill with emphasis on diet-related changes in plasma tHcy and TMAO. Thus, we 
Mar. Drugs 2015, 13 5709 
 
 
measured the effect of PPC on the Met-Hcy cycle, transsulfuration pathway, vitamin B status and 
hepatic gene expression, as well as plasma levels of choline, betaine, carnitine, and carnitine 
precursors, all linked to TMAO generation. 
2. Results 
2.1. Metabolites of the Methionine-Homocysteine Cycle 
The plasma levels of tHcy (Figure 2A) were significantly reduced by 11% PPC feeding compared to 
control. The plasma levels of Met did not differ between the groups (Figure 2B), whereas the plasma 
levels of Met sulfoxide were significantly increased in the 11% PPC-fed rats (Figure 2C). Along the 
transsulfuration pathway the plasma level of cysteine demonstrated a small, but significantly increase 
in the 11% PPC-fed rats compared to control (Figure 2D). However, there was no inverse correlation 
between the tHcy and cysteine plasma levels (R = −0.051, p = 0.851, n = 16). Along the choline 
oxidation pathway, the PPC-fed rats had higher levels of plasma DMG (Figure 2E), while the plasma 
level of betaine did not differ statistically between the groups (Figure 2F). A tendency to negative 
correlation was observed between plasma levels of DMG and tHcy (R = −0.454, p = 0.077, n = 16). No 
significant changes in the hepatic gene expression of enzymes involved in Hcy remethylation and 
sulfoxation or transsulfuration, or choline biosynthesis were observed (Table S1). 
 
Figure 2. Plasma levels of metabolites of the transsulfuration and homocysteine 
remethylation pathways. Rats were fed either a control diet (2% soy oil, 8% lard, 20% casein), 
or an experimental diet where casein and lard were replaced with phospholipid-protein 
complex (PPC) at 6% or 11% (wt%) for 4 weeks. Total homocysteine (tHcy; A), methionine 
(Met; B), Met sulfoxide (C), cysteine (D), dimethylglycine (DMG; E), and betaine (F) 
were measured in fasting plasma samples. Values shown are means with standard deviation 
(n = 6). One-way analysis of variance (ANOVA) with Dunnet’s post hoc test was used to 
determine values significantly different from control (* p < 0.05, ** p < 0.01, *** p < 0.001). 
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2.2. Vitamin B Levels 
Among the B-vitamins, higher levels of plasma quinolinic acid (vitamin B3, Figure 3A), pyroxidal 
phosphate (PLP; vitamin B6, Figure 3B), and cobalamin (vitamin B12, Figure 3C), was measured in 
the 11% PPC-fed rats compared to controls. The plasma levels of 5-mTHF (activated form of 
folate/vitamin B9) did not differ between the groups (Figure 3D). In addition, no differences in plasma 
riboflavin (vitamin B2), flavin mononucleotide (FMN; a biomolecule produced from riboflavin), 
nicotinamid (vitamin B3), N’-methylnicotinamid (metabolite of nicotinamid), pyridoxic acid (form of 
vitamin B6), and pyridoxal (form of vitamin B6) were found in the PPC-fed rats versus controls 
(Figure S1). 
 
Figure 3. Plasma levels of B-vitamins and derivatives. Male Wistar rats were fed either a 
control diet (2% soy oil, 8% lard, 20% casein), or an experimental diet where casein and 
lard were replaced with phospholipid-protein complex (PPC) at 6% or 11% (wt. %) for 4 
weeks. Quinolinic acid (vitamin B3, A), pyridoxal phosphate (PLP; vitamin B6, B), 
cobalamin (vitamin B12, C), and 5-methyltetrahydrofolate (5-mTHF; D) were measured in 
fasting plasma samples. Values shown are means with standard deviation (n = 6). One-way 
analysis of variance (ANOVA) with Dunnet’s post hoc test was used to determine values 
significantly different from control (* p < 0.05). 
2.3. Choline, Carnitine, Carnitine Precursors and TMAO 
PPC is rich in PC, and is a natural source of TMAO, but has low concentrations of carnitine, 
carnitine precursors as well as free choline (Table 1). After PPC-feeding the plasma level of choline 
was increased in the 11% PPC-fed rats compared to the control-fed rats (Figure 4A), whereas the 
plasma levels of TMAO were increased by both doses of PPC (Figure 4B). The plasma levels of 
carnitine and the intermediates in carnitine biosynthesis, trimethyllysine (TML) and γ-butyrobetaine, 
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were significantly increased by PPC-feeding compared to control (Figure 4C–E). Further, a close 
correlation between plasma TMAO and TML, carnitine and γ-butyrobetaine, but not choline was found 
(Figure 5). 
Table 1. Contents of free choline, carnitine, carnitine precursors and trimethylamine-N-oxide 
(TMAO) (µmol/100 g) in the control and 11% phospholipid-protein complex (PPC) diets. 
Organic Compound Control 1 11% PPC 
TMAO <0.001 12.6 
Free choline 17.1 20.9 
Betaine <0.001 3.9 
Carnitine 0.25 0.27 
γ-Butyrobetaine <0.001 0.009 
TML <0.001 0.003 
TMA 1 - 7.06 
1 Calculated from commercial analysis of phospholipid-protein complex (PPC), and assumed not to be 
present in the control diet. Abbreviations: PC, phosphatidyl choline; TMA, trimethylamine; TMAO, 
trimethylamine-N-oxide; TML, trimethyllysine. 
 
Figure 4. Plasma levels of phosphatidylcholine (PC) degradation products and carnitine 
precursors. Male Wistar rats were fed either a control diet (2% soy oil, 8% lard, 20% casein), 
or an experimental diet where casein and lard were replaced with phospholipid-protein 
complex (PPC) at 6% or 11% (wt%) for four weeks. Choline (A), trimethylamine-N-oxide 
(TMAO; B), carnitine (C), γ-butyrobetaine (D) and trimethyllysine (TML; E) were 
measured in fasting plasma samples. Values shown are means with standard deviation (n = 6). 
One-way analysis of variance (ANOVA) with Dunnet’s post hoc test was used to determine 
values significantly different from control (** p < 0.01, *** p < 0.001). 




Figure 5. Correlation between trimethylamine-N-oxide (TMAO) and intermediates in 
TMAO synthesis. Plasma levels of TMAO and trimethyllysine (A), TMAO and carnitine 
(B), TMAO and γ-butyrobetaine (C), and TMAO and choline (D), were analyzed by linear 
regression. Data were obtained as described under legend to Figure 4. Control group is 
depicted in green, 6% phospholipid-protein complex (PPC) in blue, and 11% PPC in red. 
3. Discussion 
The role of n-3 PUFA supplementation in the regulation of risk factors for cardiovascular disease 
has been analyzed in numerous studies, and krill oil in particular has many promising effects based on 
its high bioavailability (reviewed by [32]). We have previously shown that PPC from krill lowers 
plasma TAG and cholesterol levels in male Wistar rats [33]. The present study focused on plasma 
parameters where the effects of krill supplements are unknown; tHcy and the newly established risk 
factor TMAO. We demonstrate that 11% PPC influenced Met-Hcy cycle metabolites including choline 
and DMG, as well as the vitamin B status, compared to a control diet. In addition, PPC-feeding altered 
the plasma level of TMAO compared to control. Further, the increase in TMAO positively correlated 
with plasma carnitine and carnitine precursors. 
As hyperhomocysteinemia is an established risk factor for coronary artery disease [7,34–36], it was 
of interest to note that the plasma tHcy level was significantly decreased by PPC supplementation.  
A recent meta-analysis of intervention studies show that n-3 PUFA supplementation is associated with 
reduced plasma tHcy levels [22], which is in line with our findings. Compared to the control diet, the 
PPC diets contained high levels of betaine (Table 1), as well as choline from the PC component. A 
high dietary intake of choline and betaine has been linked to reduction in tHcy levels [37,38]. While a 
number of studies indicate a lower risk of CVD after long term choline and betaine intake, by the 
ability to lower inflammatory biomarkers and counteract oxidative stress caused by high Hcy 
(reviewed in [39]), an association to survival has not been confirmed in cohort studies [40]. In the 
present study the plasma level of betaine was unchanged while the DMG level increased in the  
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PPC-fed rats compared to controls. This indicates higher activity of BHMT-dependent Hcy 
remethylation with betaine as methyldonor (Figure 1), supported by a strong tendency to negative 
correlation between plasma levels of tHcy and DMG. As DMG is implicated in the regulation of 
glucose metabolism, and low DMG levels are associated with higher blood glucose levels [41], dietary 
regulation of this factor could prove useful in the prevention of diabetes mellitus type 2. 
Vitamin cofactors are important in the different pathways regulating tHcy. The plasma content of 
quinolinic acid, a metabolite associated with vitamin B3, was higher in the 11% PPC group, and could 
increase enzyme activities of BHMT and MSR. The lower level of tHcy could also be the consequence 
of increased activity of MS as a higher plasma level of cobalamin (vitamin B12) resulting after  
PPC-feeding. Thus, Hcy remethylation involving both 5-mTHF and betaine as methyl donors was 
potentially increased by 11% PPC. 
Likewise, the higher level of pyridoxal phosphate, an active metabolite of vitamin-B6, could 
increase enzyme activities of CBS and CTH, activating the transsulfuration pathway important in the 
Hcy elimination process. In the present study, the product of this reaction, plasma cysteine, was 
significantly higher in the 11% PPC-fed rats than in controls. In rats supplemented with DHA from 
tuna oil, plasma tHcy was reduced partly through upregulation of hepatic transsulfuration [42]. Thus, 
the n-3 PUFA component in the PPC diet could have contributed to the reduction of tHcy through 
effects on transsulfuration. However, as there was no negative correlation between plasma levels of 
tHcy and cysteine, the transsulfuration pathway could be less important than remethylation in the 
regulation of plasma tHcy after PPC-feeding. 
An elevated plasma level of microbiota-derived TMAO has been found to promote arteriosclerosis 
in animal studies, and is associated with increased risk of adverse cardiovascular events. However, as 
seafood contains high levels of TMAO [43], and is generally considered beneficial for health, this is 
somewhat contradictory. Crustaceans are a natural source of TMAO, as TMAO is synthesized directly 
from choline in vivo and functions to counteract protein-destabilization in deep-sea organisms [28,31,44]. 
Although the necessary enzymes for this process have been identified in mammals [45], TMAO is 
formed in the liver from gut-derived trimethylamine (TMA) generated from dietary choline and 
carnitine [25,26]. In the present study, PPC-feeding increased the plasma levels of TMAO, choline, 
carnitine and its precursors TML and γ-butyrobutaine (Figure 4). As the PPC contain low amounts of  
γ-butyrobetaine, TML, and carnitine, but high amounts of TMAO and TMA, the increased plasma 
level of TMAO in the PPC-fed rats could be due to direct dietary uptake (Table 1). In addition, PPC’s 
content of PC (17 g PC/100 g 11% PPC diet) may have contributed to plasma TMAO levels through 
microbial activity. However, there was no correlation between plasma choline and TMAO in rats fed PPC 
(Figure 5). Moreover, unpublished material from a recently conducted intervention study with 
phospholipids, predominantly PC, from herring roe (1.7 g PL/day for two weeks) showed no increase 
in plasma TMAO levels in healthy young adults (Table S2) [46]. Importantly, there seem to be a link 
between TMAO, choline and betaine in their prognostic value [47], and positive associations to 
cardiovascular risk are more prominent in diabetic subjects, indicating that control of osmolyte 
retention in tissues could be important [48]. Further studies are needed to determine the effect of 
seafood-derived TMAO on these processes. 
As carnitine is a precursor of TMAO [49], the close positive correlation between plasma TMAO 
and carnitine and its precursors was intriguing. However, in the current study, it was not possible to 
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connect this to dietary intake of carnitine. The observation could suggest a concomitant increase in 
plasma TMAO, due to dietary intake, and carnitine, due to increased biosynthesis. Krill oil has 
previously been shown to increase the plasma carnitine level, but not the level of carnitine precursors 
in mice [50]. Interestingly, while choline-supplementation was shown to reduce serum carnitine levels 
in humans [51], betaine increases carnitine production in mice [52]. This indicates that the higher 
betaine-level in the PPC diets could result in stimulated carnitine biosynthesis. Thus, the increased 
plasma levels of both carnitine and carnitine precursors in the PPC-fed rats could partly be due to 
PPC’s content of n-3 PUFA-rich oil, and partly an increased betaine intake. L-Carnitine 
supplementation improves lipid metabolism in obese rats [53], but does not affect cardiovascular risk 
in humans [54]. Further studies are needed to determine a possible beneficial effect of increased 
carnitine biosynthesis on metabolic disease. 
4. Materials and Methods 
4.1. Animals and Diets 
The animal study was conducted according to the Guidelines for the Care and Use of Experimental 
Animals, and in accordance with the Norwegian legislation and regulations governing experiments 
using live animals. The Norwegian State Board of Biological Experiments with Living Animals 
approved the protocol (Permit number 2013-5324). All efforts were made to optimize the animal 
environment, and minimize suffering. 
Male Wistar rats, aged 5 to 6 weeks (Taconic Tornbjergvej facility, Elby, Denmark), were 
randomized and housed pair wise in open cages (n = 6 rats per group). They were kept under standard 
laboratory conditions with temperature 22 ± 1 °C, dark/light cycles of 12/12 h, relative humidity 43% 
± 5%, and 20 air changes per hour. The rats were acclimatized under these conditions for one week 
prior to study start, with free access to standard chow and water. 
The rats were fed ad libitum for 4 weeks on a 10% fat diet, either as a control diet (2% soy oil,  
8% lard, 20% casein, wt.%) or an experimental diet, where casein and lard were replaced with PPC at 
6% or 11% (wt.%). See Ramsvik et al. for a detailed description of the diet ingredients [33]. Krill PPC, 
an Antarctic krill meal from Euphausia superba (RIMFROST GENUINE®), was delivered by Olympic 
Seafood AS (Fosnavaag, Norway). The PPC consisted of 46.4% protein and 45.7% fat, and contained 
39.0 g phosphatidylcholine, 13 g eicosapentaenoic acid (EPA, C20:5n-3), and 7.9 g docosahexaenoic 
acid (DHA, C22:6n-3) per 100 g extracted fat. The fatty acid composition of the PPC and the amino 
acid composition in casein and the PPC are presented in Tables 2 and 3, respectively. Feed intake and 
weight gain were determined twice a week. All rats were killed on day 28. They were anesthetized by 
inhalation of 2% Isofluorane (Forane, from Abbot Laboratories Ltd., Abbott Park, IL, USA) and 
thoracotomy, cardiac puncture, and exsanguination was performed. Plasma and liver samples were 
stored at −80 °C. 
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Table 2. Lipids and fatty acid composition (wt%) of the phospholipid-protein  
complex (PPC). 







C18:1(n-9) + (n-7) + (n-5) 12.7 
C20:1(n-9) + (n-7) 0.6 
C22:1(n-11) + (n-9) + (n-7) 0.3 
C24:1n-9 <0.01 




C20:4n-6 (AA) 0.1 
C22:4n-6 <0.1 




C20:5n-3 (EPA) 13.0 
C21:5n-3 0.5 
C22:5n-3 (DPA) 0.4 
C22:6n-3 (DHA) 7.9 
∑SFAs  23.6 
∑MUFAs 16.2 
∑PUFAs 35.1 
n-6 PUFAs 1.8 
n-3 PUFAs 32.5 
Sum of fatty acids 74.9 
Lipids  
Total polar lipids 46.9 
Total neutral lipids 53.1 
Sum of lipids 100 
1 Fat (wt%) Bligh & Dyer, g/100 g extracted lipids. Abbreviations: AA, arachidonic acid; ALA, alpha 
linolenic acid; DHA, docosahexaenoic acid; DPA, docosapentaenoic acid; EPA, eicosapentaenoic acid; LA, 
linoleic acid; MUFAs, monounsaturated fatty acids; PUFAs, polyunsaturated fatty acids; SFAs, saturated 
fatty acids. 
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Table 3. Amino acid composition in casein and the phospholipid-protein complex (PPC). 
Amino acid 1 
Dietary Component 
Casein 2 PPC 3 
Aspartic acid 6.5  10.6 
Glutaminic acid 20.8 12.7 
Hydroksyproline - <0.01 
Serine 5.4 4.8 
Glycine 1.8 4.6 
Histidine 2.6 2.7 
Arginine 3.6 6.2 
Threonine 3.8 5.4 
Alanine 2.6 5.1 
Proline 11.7 4.5 
Tyrosine 5.3 4.7 
Valine 5.7 5.8 
Methionine 2.6 3.3 
Isoleucine 4.8 6.5 
Leucine 8.8 8.8 
Phenylalanine 5.0 5.4 
Lysine 7.4 9.0 
Cysteine 0.4 - 
Tryptophan 1.2 - 
Methionine/glycine 1.4 0.7 
Lysine/arginine 2.1 1.5 
1 g amino acid/100 g of protein; 2 Values given by the manufacturer; 3 Analyzed values. 
4.2. Biochemical Analyses 
Plasma trimethyllysine (TML), choline, betaine, DMG and TMAO were analyzed by liquid 
chromatography-mass spectrometry [27,46]. Met, Met sulfoxide, tHcy, cystathione, and cysteine were 
analyzed by gas chromatography-mass spectrometry [55]. Vitamin B status (flavin mononucleotide 
(FMN), riboflavin, nicotinic acid, quinolinic acid, pyridoxal phosphate (PLP), pyridoxal, pyridoxic 
acid, folate, and cobalamin) was measured as previously described [55]. 
4.3. Statistical Analysis 
Data sets were analyzed using Prism Software (Graph-Pad Software, San Diego, CA, USA) to 
determine statistical significance. The results are shown as means of 6 animals per group with their 
standard deviations. Normal distribution was determined by the Kolmogorov-Smirnov test (with  
Dallal-Wilkinson-Lilliefor corrected p-value). One-way analysis of variance (ANOVA) with Dunnet’s 
post hoc test was used to evaluate statistical differences between groups. Unpaired t-test test was used 
for the gene analysis. Pearson’s correlation coefficient (R) was calculated to measure linear 
dependence between plasma metabolites. p-Values < 0.05 were considered significant. 
  




A phospholipid-protein complex from krill reduced plasma tHcy levels, possibly associated with the 
n-3 PUFA, choline and betaine content of the diet, which suggest a positive health effect of PPC. On 
the other hand, a higher plasma level of TMAO, as observed in the PPC-fed rats, can potentially 
increase the risk of cardiovascular disease. Importantly, this increase seemed to be mainly due to direct 
uptake of TMAO from the PPC and not through microbiota-dependent mechanisms. As seafood has 
been shown to improve cardiovascular health, beneficial effects could counteract the possible negative 
effect of TMAO uptake. Whether TMAO from seafood in fact has negative effects when not generated 
from TMA produced in the intestines has yet to be determined. Although there was a significant 
correlation between plasma carnitine, TML and TMAO in rats, this was not due to TMA generation 
from carnitine and TML by microbiota, but rather a stimulation of carnitine biosynthesis dependent on 
PPC-intake. 
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Figure S1: Plasma levels of riboflavin, FMN, nicotinamid, N’-methylnicotinamid, pyridoxic acid, 
pyridoxal, and folate. 
Table S1: Hepatic expression of genes involved in choline metabolism, the methionine-homocysteine 
cycle, and homocysteine transsulfuration. 
Table S2: Trimethylamine-N-oxide (TMAO) levels in plasma after 2 weeks supplementation with 
phosphatidylcholine from herring roe in healthy young adults (unpublished results). 
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